whole-transcriptome microarray data decipher (Veracyte Inc)
90
Structured Review
Veracyte Inc
whole-transcriptome microarray data decipher
Whole Transcriptome Microarray Data Decipher, supplied by Veracyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+data+microarray/whole+transcriptome+decipher+assay/10__1172_slash_jci165718-366-6-7
Average 90 stars, based on 1 article reviews
Whole Transcriptome Microarray Data Decipher, supplied by Veracyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+data+microarray/whole+transcriptome+decipher+assay/10__1172_slash_jci165718-366-6-7
Average 90 stars, based on 1 article reviews
whole-transcriptome microarray data decipher - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Magnetic Resonance Imaging:Article Title: The Evolving Management of Radiorecurrent Prostate Cancer. Article Snippet: Department of Intern wood, IL. yDepartment of Radia Bernardin Cancer C zDepartment of Radia Los Angels, CA. xDepartment of Radia setts General Hosp Department of Radia {Division of Radiation British Columbia, Academic Departmen France.. Centre National de CRIStAL UMR 918 yyDepartment of Radi Medical Center, Ch zzRadiation Oncology Los Angeles, Los A xxRadiation Oncology Funding: This work w ber I01 CX002277 Affairs Clinical Scie Address reprint reques tion Oncology, Str Edward Hines J asolanki@luc.edu Clinical Proteomics:Article Title: Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials. Article Snippet: .. Details on the translational research project investigating genomic markers and ethical approval have been previously described.12 Genomic signatures were generated using the whole Article Title: Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials. Article Snippet: .. SAKK 09/10 The SAKK 09/10 randomized phase III trial tested whether dose-escalated SRT is superior to conventional dose SRT with respect to freedom from biochemical progression.4 More details on study exclusion and inclusion criteria are available at ClinicalTrials.gov (NCT01272050), and details on the translational research project investigating genomic markers and ethical approval have been previously described.7 Genomic signatures were generated using the whole Generated:Article Title: Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials. Article Snippet: .. Details on the translational research project investigating genomic markers and ethical approval have been previously described.12 Genomic signatures were generated using the whole Article Title: Transcriptome-Based Prognostic and Predictive Biomarker Analysis of ENACT: A Randomized Controlled Trial of Enzalutamide in Men Undergoing Active Surveillance Article Snippet: .. Tumor expression profiles were generated from biopsies obtained at screening, year 1, and year 2 (Data Supplement, Fig S1) of ≥0.5 mm of tumor linear length using a Article Title: Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials. Article Snippet: .. SAKK 09/10 The SAKK 09/10 randomized phase III trial tested whether dose-escalated SRT is superior to conventional dose SRT with respect to freedom from biochemical progression.4 More details on study exclusion and inclusion criteria are available at ClinicalTrials.gov (NCT01272050), and details on the translational research project investigating genomic markers and ethical approval have been previously described.7 Genomic signatures were generated using the whole Expressing:Article Title: Transcriptome-Based Prognostic and Predictive Biomarker Analysis of ENACT: A Randomized Controlled Trial of Enzalutamide in Men Undergoing Active Surveillance Article Snippet: .. Tumor expression profiles were generated from biopsies obtained at screening, year 1, and year 2 (Data Supplement, Fig S1) of ≥0.5 mm of tumor linear length using a Microarray:Article Title: Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancer Article Snippet: .. Normalized Gene Expression:Article Title: Robotische Nierenteilresektion in Patient* innen mit Einzelniere – Eine multizentrische Analyse Article Snippet: Medizinische Hochschule Hannover, Klinik für Urologie und Urologische Onkologie, Hannover, Deutschland; Klinikum Würzburg Mitte – Missioklinik, Klinik für Urologie, Würzburg, Deutschland; Urologische Klinik München – Planegg, Planegg, Deutschland; Klinikum Wels-Grieskirchen GmbH, Abteilung für Urologie, Wels, Österreich; Augusta-Kranken-Anstalt Bochum, Klinik für Urologie, Bochum, Deutschland; Universität Witten/Herdecke, Lehrstuhl für Urologie, Bochum, Deutschland; Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Urologie, Kiel, Deutschland; St. Antonius Hospital Gronau, Klinik für Urologie, Gronau, Deutschland; Universitätsklinik Essen, Klinik für Urologie, Essen, Deutschland; Universitätsklinik des Saarlaands, Klinik für Urologie und Kinderurologie, Homburg/Saar, Deutschland other:Article Title: EANM'24 Abstract Book Congress Oct 19-23, 2024. Article Snippet: European Journal of Nuclear Medicine and Molecular Imaging (2024) 51 (Suppl 1): S1–S1024 This supplement was not sponsored by outside commercial interests.. It was funded entirely by the association’s own resources.. European Journal of Nuclear Medicine and Molecular Imaging (2024) 51 (Suppl 1): S1–S1024 S1 10.1007/s00259-024-06838-z Eur J Nucl Med Mol Imaging (2024) 51 (Suppl 1): S1–S1024 S2 |
